Login / Signup

Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.

John M SandersDouglas C BeshoreJ Christopher CulbersonJames I FellsJason E ImbriglioHakan GunaydinAndrew M HaidleMarc LabroliBrian E MattioniNunzio SciammettaWilliam D ShipeRobert P SheridanLinda M SuenAndreas VerrasAbbas WaljiElizabeth M JoshiTjerk Bueters
Published in: Journal of medicinal chemistry (2017)
High-throughput screening (HTS) has enabled millions of compounds to be assessed for biological activity, but challenges remain in the prioritization of hit series. While biological, absorption, distribution, metabolism, excretion, and toxicity (ADMET), purity, and structural data are routinely used to select chemical matter for further follow-up, the scarcity of historical ADMET data for screening hits limits our understanding of early hit compounds. Herein, we describe a process that utilizes a battery of in-house quantitative structure-activity relationship (QSAR) models to generate in silico ADMET profiles for hit series to enable more complete characterizations of HTS chemical matter. These profiles allow teams to quickly assess hit series for desirable ADMET properties or suspected liabilities that may require significant optimization. Accordingly, these in silico data can direct ADMET experimentation and profoundly impact the progression of hit series. Several prospective examples are presented to substantiate the value of this approach.
Keyphrases
  • molecular docking
  • molecular dynamics simulations
  • electronic health record
  • structure activity relationship
  • big data
  • oxidative stress
  • pulmonary embolism
  • data analysis
  • molecular dynamics
  • mass spectrometry